Egypt Opens First Phase of Vaccine and Biotechnology City

Egyptian health authorities inaugurated the first phase of the Vaccine and Biotechnology City on Monday, marking a step toward expanding the country’s pharmaceutical manufacturing capabilities.

The project aims to strengthen Egypt’s capacity to produce vaccines for both human and veterinary use, placing the two fields within a broader drive to develop domestic production.

Reducing reliance on imported vaccines is a central goal of the initiative, with local manufacturing intended to play a larger role in meeting the country’s needs.

The city is also intended to build a production and technological base that can support further expansion in vaccine manufacturing.

Beyond the domestic market, the project’s ambitions include exports to overseas markets as Egypt develops its manufacturing capacity.